Quick Info!
Search for Studies. Example: "Breast Cancer"
2 results found !
- 39808518
- 202091 (EBOLA Z CHAD3-005):Safety and immunogenicity study of GSK Biologicals’ investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (GSK3390107A) in adults in Africa
- Using the investigational EBOV vaccine encoded by chimpanzee-derived adenovirus (ChAd3-EBO-Z) dose selected during the Phase 1 stage, the present Phase 2, randomised, placebo-controlled trial will aim at collecting robust safety and immunogenicity data following a single intramuscular (IM) dose of the investigational ChAd3-EBO-Z vaccine.
- 2017-09-18
- 26989548
- Safety and immunogenicity study of GSK Biologicals’
- The present Phase 2,
randomised, controlled trial will aim at collecting safety and immunogenicity data
following a single intramuscular (IM) dose of the investigational ChAd3-EBO-Z vaccine. The study will be conducted in healthy children living in countries adjacent to the current
Ebola outbreak zones.
- 2015-10-02